SN
Senti Biosciences, Inc.
SNTI · NASDAQ
$0.31 +2.00% (+$0.01)
1M -31.85%
Market Cap $9.35M
P/E Ratio -
Div. Yield -
ROE 1,539.97%
Bulios Fair Price
$0.38
24.2% upside
Trenutna cena
$0.31
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNTI trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 246.04x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 81.15%
Book val. growth 64.72%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 4,628.95%
Net margin 130,432.00%
FCF margin 100,134.00%
Quality
0 /100
Poor ROIC 227.67%
ROE 1,539.97%
Asset turnover 0.00x
Debt
27 /100
High Current ratio 0.83x
Debt/Equity N/A
Int. coverage N/A
Stability
6 /100
Unstable Beta 2.12x
EPS volatility 70.29%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNTI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy K. Lu
Employees
39
Headquarters
South San Francisco
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report